Huntington’s disease research news. In plain language. Written by scientists. For the global HD community.
Good morning from the final day of the 2018 HD Therapeutics Conference! Two sessions today, the first focused on the protein made from the HD gene. The second includes updates on Huntingtin Lowering Trials from both Wave Life Sciences and Ionis Pharmaceuticals.
Updates from day 2 of the Huntington's Disease Therapeutics Conference focusing on DNA repair in HD.
Jeff and Ed report from the Huntington's Disease Therapeutics Conference - the biggest annual gathering of HD researchers. This year's conference is bigger and more exciting than ever.
Hi everyone! It's the annual Huntington's Disease Therapeutics Conference in Malta. Around 350 scientists from round the world all working on HD are gathered here to discuss the latest research developments. We're reporting live via twitter and aggregating our updates into daily articles.
The third and final day of the 2016 Huntington's Disease Therapeutics Conference brings updates on cell replacement therapies including stem cells; and new ways to assess and model the progression of HD to help understand it and run crucial clinical trials.
If it's February, that means the the world's leading scientists are converging on Palm Springs for the annual HD therapeutics conference!
Our second update from the Annual Huntington's Disease Therapeutics Conference.
The first of our special reports from the Annual Huntington's Disease Therapeutics Conference in Palm Springs – the biggest meeting of HD scientists focused on developing treatments to prevent or slow Huntington's disease.
Our final reports from the Huntington's disease therapeutics conference in Palm Springs.